SHC Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

SHC Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.3.0.583 SC130669 Board of Directors 1.4.20 31.3.21 31.3.21 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC1306692020-03-31SC1306692021-03-31SC1306692020-04-012021-03-31SC1306692019-03-31SC1306692019-04-012020-03-31SC1306692020-03-31SC130669ns16:Scotland2020-04-012021-03-31SC130669ns15:PoundSterling2020-04-012021-03-31SC130669ns11:Director12020-04-012021-03-31SC130669ns11:PrivateLimitedCompanyLtd2020-04-012021-03-31SC130669ns11:SmallEntities2020-04-012021-03-31SC130669ns11:AuditExempt-NoAccountantsReport2020-04-012021-03-31SC130669ns11:SmallCompaniesRegimeForDirectorsReport2020-04-012021-03-31SC130669ns11:SmallCompaniesRegimeForAccounts2020-04-012021-03-31SC130669ns11:AbridgedAccounts2020-04-012021-03-31SC130669ns11:Director22020-04-012021-03-31SC130669ns11:CompanySecretary12020-04-012021-03-31SC130669ns11:RegisteredOffice2020-04-012021-03-31SC130669ns6:CurrentFinancialInstruments2021-03-31SC130669ns6:CurrentFinancialInstruments2020-03-31SC130669ns6:ShareCapital2021-03-31SC130669ns6:ShareCapital2020-03-31SC130669ns6:RetainedEarningsAccumulatedLosses2021-03-31SC130669ns6:RetainedEarningsAccumulatedLosses2020-03-31SC130669ns6:PlantMachinery2020-04-012021-03-31SC130669ns6:FurnitureFittings2020-04-012021-03-31SC130669ns6:ComputerEquipment2020-04-012021-03-31
REGISTERED NUMBER: SC130669 (Scotland)















Financial Statements For The Year Ended 31 March 2021

for

SHC Pharmacy Limited

SHC Pharmacy Limited (Registered number: SC130669)






Contents of the Financial Statements
For The Year Ended 31 March 2021




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


SHC Pharmacy Limited

Company Information
For The Year Ended 31 March 2021







DIRECTORS: S C Marnell
C Shanks





SECRETARY: C Shanks





REGISTERED OFFICE: Sighthill Health Centre
Calder Road
Edinburgh
EH11 4AU





REGISTERED NUMBER: SC130669 (Scotland)





ACCOUNTANTS: Robb Ferguson Chartered Accountants
Regent Court
70 West Regent Street
Glasgow
G2 2QZ

SHC Pharmacy Limited (Registered number: SC130669)

Abridged Statement of Financial Position
31 March 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 820 1,150

CURRENT ASSETS
Stocks 89,737 73,339
Debtors 254,535 198,990
Cash at bank and in hand 200,967 205,830
545,239 478,159
CREDITORS
Amounts falling due within one year 536,067 400,578
NET CURRENT ASSETS 9,172 77,581
TOTAL ASSETS LESS CURRENT
LIABILITIES

9,992

78,731

PROVISIONS FOR LIABILITIES 68 112
NET ASSETS 9,924 78,619

CAPITAL AND RESERVES
Called up share capital 60 60
Retained earnings 9,864 78,559
9,924 78,619

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SHC Pharmacy Limited (Registered number: SC130669)

Abridged Statement of Financial Position - continued
31 March 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Comprehensive Income and an abridged Statement of Financial Position for the year ended 31 March 2021 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 November 2021 and were signed on its behalf by:





S C Marnell - Director


SHC Pharmacy Limited (Registered number: SC130669)

Notes to the Financial Statements
For The Year Ended 31 March 2021

1. STATUTORY INFORMATION

SHC Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is recognised at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to the customer net of discounts, VAT and other sales-related taxes.

Turnover from sale of goods is recognised when the risk and rewards of ownership of the goods have transferred to the buyer.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 10% on cost
Computer Equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

SHC Pharmacy Limited (Registered number: SC130669)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2021

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2020 - 13 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2020
and 31 March 2021 21,409
DEPRECIATION
At 1 April 2020 20,259
Charge for year 330
At 31 March 2021 20,589
NET BOOK VALUE
At 31 March 2021 820
At 31 March 2020 1,150

5. RELATED PARTY DISCLOSURES

At the year end there was an amount due from ARM Pharmacy Ltd, a company in which S Marnell is a director, of £23,333
(2020: NIL).

At the year end there was an amount due from Calder Pharmacy Limited, a company in which C Shanks is a director, of
£11,667 (2020: NIL).